SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,122,882 | +222.5% | 346,107 | +636.8% | 0.01% | +200.0% |
| Q2 2023 | $2,208,623 | -26.6% | 46,972 | -34.5% | 0.00% | -25.0% |
| Q1 2023 | $3,007,525 | -24.4% | 71,676 | -31.2% | 0.00% | -33.3% |
| Q4 2022 | $3,975,714 | -99.9% | 104,240 | -13.7% | 0.01% | -25.0% |
| Q3 2022 | $4,731,664,000 | +43.6% | 120,829 | +18.4% | 0.01% | +60.0% |
| Q2 2022 | $3,295,407,000 | +346.8% | 102,025 | +357.8% | 0.01% | +400.0% |
| Q1 2022 | $737,634,000 | +211.3% | 22,285 | +300.1% | 0.00% | – |
| Q4 2021 | $236,948,000 | +10.4% | 5,570 | +15.0% | 0.00% | – |
| Q3 2021 | $214,682,000 | +92.9% | 4,845 | +147.3% | 0.00% | – |
| Q2 2021 | $111,291,000 | +448.7% | 1,959 | +622.9% | 0.00% | – |
| Q1 2021 | $20,284,000 | -89.6% | 271 | -88.0% | 0.00% | – |
| Q4 2020 | $194,561,000 | +208.8% | 2,249 | +118.1% | 0.00% | – |
| Q3 2020 | $63,015,000 | -98.5% | 1,031 | -99.0% | 0.00% | -100.0% |
| Q2 2020 | $4,308,353,000 | +290.6% | 103,616 | +169.8% | 0.01% | +300.0% |
| Q1 2020 | $1,102,877,000 | -26.7% | 38,401 | +84.3% | 0.00% | -33.3% |
| Q4 2019 | $1,504,223,000 | +105.1% | 20,837 | +298.6% | 0.00% | +200.0% |
| Q3 2019 | $733,436,000 | +1.4% | 5,228 | +32.3% | 0.00% | 0.0% |
| Q2 2019 | $723,389,000 | -25.5% | 3,951 | -35.3% | 0.00% | -50.0% |
| Q1 2019 | $971,318,000 | -25.3% | 6,107 | -55.0% | 0.00% | -33.3% |
| Q4 2018 | $1,300,445,000 | -0.5% | 13,576 | +46.7% | 0.00% | +50.0% |
| Q3 2018 | $1,307,410,000 | +252.3% | 9,256 | +290.4% | 0.00% | +100.0% |
| Q2 2018 | $371,133,000 | -76.2% | 2,371 | -75.6% | 0.00% | -66.7% |
| Q1 2018 | $1,562,057,000 | +20.1% | 9,698 | +22.9% | 0.00% | +50.0% |
| Q4 2017 | $1,300,221,000 | +201.5% | 7,894 | +14.0% | 0.00% | +100.0% |
| Q3 2017 | $431,241,000 | +26.0% | 6,922 | +61.1% | 0.00% | 0.0% |
| Q2 2017 | $342,133,000 | +674.0% | 4,296 | +590.7% | 0.00% | – |
| Q1 2017 | $44,206,000 | -60.7% | 622 | -71.8% | 0.00% | -100.0% |
| Q4 2016 | $112,536,000 | +3.2% | 2,204 | -7.0% | 0.00% | – |
| Q3 2016 | $109,092,000 | +250.2% | 2,369 | +129.1% | 0.00% | – |
| Q2 2016 | $31,154,000 | -84.0% | 1,034 | -69.0% | 0.00% | – |
| Q4 2015 | $194,722,000 | +56.5% | 3,340 | +13.6% | 0.00% | – |
| Q3 2015 | $124,421,000 | +48.6% | 2,940 | +156.3% | 0.00% | – |
| Q2 2015 | $83,731,000 | +1172.5% | 1,147 | +775.6% | 0.00% | – |
| Q1 2015 | $6,580,000 | – | 131 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |